EMA rewrites medicine approval policy
New innovative medicines should be made available to European citizens more quickly. That is why the European Medicines Agency updates the process for market authorisation. Anthony Humphreys sighs when asked what the new strategy means for doctors. ‘What can I possibly say?’ The former pharmacist from Ireland is responsible for EMA’s ‘Regulatory Science to 2025’ …
